| Ovarian Cancer |
1 |
1 |
| Breast Cancer |
0 |
0.9 |
| Cancer |
0 |
0.7 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.62 |
| Peritoneal Cancer |
0 |
0.55 |
| BRCA |
0 |
0.23 |
| Chemotherapy |
0 |
0.23 |
| Revenue and Practice Management |
0 |
0.99 |
| Clinical Research |
0 |
0.08 |
| Fallopian Tube |
0 |
0.08 |
| Platinum |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.07 |